Merck expands life science production capacities in US

World |  News | 0 Comment | 08 Dec, 2020

Merck, a leading science and technology company, has announced the broadening of its manufacturing footprint with a comb...Read more

INOVIO expands global manufacturing consortium for its COVID-19 vaccine candidate

World |  News | 0 Comment | 04 Dec, 2020

INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...Read more

Initial COVID-19 global vaccines roll-out to see some vaccine nationalism

World |  News | 0 Comment | 04 Dec, 2020

A new report from CPhI explores the potential implications in 2021 of impending vaccine approvals, a new administration ...Read more

BioNTech-Pfizer apply CMA for COVID-19 Vaccine to the EMA

World |  News | 0 Comment | 02 Dec, 2020

BioNTech SE and Pfizer Inc. on 30 Nov 2020 have submitted a formal Application for Conditional Marketing ...Read more

COVID R&D Alliance announces first patient enrollment in COMMUNITY Trial

World |  News | 0 Comment | 02 Dec, 2020

Three members of the COVID R&D Alliance - Amgen Inc, Takeda Pharmaceutical Co Ltd and UCB announced the fi...Read more

AstraZeneca vaccine meet primary efficacy endpoint in preventing COVID-19

World |  News | 0 Comment | 27 Nov, 2020

Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vacci...Read more

WHO coordinates with DHL to deliver healthcare supplies to Pacific Islands

World |  News | 0 Comment | 26 Nov, 2020

The World Health Organization coordinated its latest cargo donation through DHL Global Forwarding (DHL), the freight spe...Read more

Sputnik V vaccine single dose to be less than $10 at international markets

World |  News | 0 Comment | 25 Nov, 2020

The cost of one dose of the Sputnik V vaccine for international markets will be less than $10. Sputnik V is a ...Read more

CEPI's collaborative task force to assess COVID-19 vaccines on emerging viral strains

World |  News | 0 Comment | 23 Nov, 2020

To rapidly monitor the emergence of new COVID-19 viral strains and evaluate their impact on vaccine candidates in develo...Read more

Pfizer, BioNTech demonstrate 95% efficacy of COVID-19 vaccine

World |  News | 0 Comment | 23 Nov, 2020

Pfizer Inc. and BioNTech have announced that, after conducting the final efficacy analysis in their ongoing Ph...Read more

WHO reports end of 11th Ebola outbreak in DRC

World |  News | 0 Comment | 19 Nov, 2020

Nearly six months after the first cases were reported in Equateur Province, the 11th Ebola outbreak in the Democratic Re...Read more

PerkinElmer launches new HPLC, UHPLC and Next Generation Software solution

World |  News | 0 Comment | 17 Nov, 2020

PerkinElmer, Inc., on 16 Nov 2020 introduced the LC 300TM platform and SimplicityChromTM softwa...Read more

IDF calls for improved funding and training of nurses

World |  News | 0 Comment | 16 Nov, 2020

This World Diabetes Day, the International Diabetes Federation (IDF) is calling for more nurses to be trained to help pe...Read more

Medtronic launches first integrated smart insulin pen for diabetics

World |  News | 0 Comment | 13 Nov, 2020

Medtronic plc has announced the launch of InPen™ integrated with real-time Guardian Connect™ CGM data. InPen...Read more

QIAGEN launches portable digital SARS-CoV-2 Ag test

World |  News | 0 Comment | 12 Nov, 2020

QIAGEN has recently started commercialization of a portable digital test in the United States that can be used by labora...Read more

PerkinElmer launches new ChemDraw application to accelerate chemistry communication workflows

World |  News | 0 Comment | 11 Nov, 2020

PerkinElmer, Inc. has launched its newest ChemDraw® application, ChemOffice®+ Cloud, to simplify, faci...Read more

EUROIMMUN launches quantitative ELISA to measure SARS-CoV-2 antibodies against Viral S1 protein

World |  News | 0 Comment | 10 Nov, 2020

PerkinElmer, Inc., announced on 9 Oct 2020 that EUROIMMUN, a PerkinElmer company, has launched the Anti-S...Read more

COVID-19 vaccine candidate by Pfizer, BioNTech shows more than 90% effectivity

World |  News | 0 Comment | 10 Nov, 2020

Pfizer Inc. and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV...Read more